Atherosclerosis and Hyperlipidemia

Breda Hennessey , Asad Shabbir , Alejandro Travieso , et al

Read time: 23 Mins
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 95m (4 videos)

Sean Fitzgerald , Maria Rubini Gimenez , Abdelhakim Allali , et al

Read time: 17 Mins

Ahmet Fuat, Gary Ford, Kausik Ray, et al

AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s

Jean-Claude Tardif,

Heather Currie , Christine Williams ,

Edward T Carreras , Donna M Polk ,

FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s

Hans-Willi Breuer ,

FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Alberto Lorenzatti , Peter P Toth ,

Ewa Dembowski , Michael H Davidson ,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

Sergio Fazio ,

Media

ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Ahmet Fuat, Gary Ford, Kausik Ray, et al

Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Watch time: 1h 6m (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

Jean-Claude Tardif,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1:27:02
ACC 2022 Late-breaker Discussion: The SuperWIN Trial

Dylan L Steen, Harriette Van Spall,

Zsolt Piroth, Hitoshi Matsuo, Evald Høj Christiansen, et al

Barbara Stähli , Stephan Kische, Tommaso Gori, et al

ACC 2021: Findings From the RESCUE Trial

Paul M Ridker,

AHA 2020: Findings from the THALES trial — Prof Pierre Amarenco

Pierre Amarenco,

ESC 2020: Final Results of the EVAPORATE Trial

Matthew J Budoff,

Media

ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 28s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s

Ahmet Fuat, Jim Moore, Gary Ford, et al

Watch time: 95m (4 videos)

Ahmet Fuat, Gary Ford, Kausik Ray, et al

AHA 22: RESPECT EPA: Eicosapentaenoic Acid for Prevention of Coronary Artery Disease

Hiroyuki Daida, Saahil A Jumkhawala,

Watch time: 14m 14s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 29s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 25s
EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani

Salim S Virani, Ankur Kalra,

Listen time: 46:28
FOURIER-OLE: Implications for Real-World Practice

Robert P Giugliano,

Watch time: 2m 56s
FOURIER-OLE: The Trial in Context

Marc S Sabatine,

Watch time: 3m 24s
FOURIER-OLE: Long-term Safety of Evolocumab Therapy in Patients with Evident ASCVD

Michelle O'Donoghue,

Watch time: 3m 30s
ESC 22: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI

David Newby,

Watch time: 3:22

Yassir Javaid, Nina Barnett, Paresh Parmar, et al

Watch time: 1h 6m (4 videos)

Prof Lale Tokgozoglu, Kausik Ray, Maciej Banach, et al

Juan Carlos Kaski, Aernoud Fiolet,

Juan-Pablo Kaski, Peter Libby,

Juan Carlos Kaski, Lina Badimon,

Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD

Juan Carlos Kaski, Paul M Ridker,

Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease

Juan Carlos Kaski, Paul M Ridker,

Jean-Claude Tardif,

Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial

Aernoud Fiolet,

4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

Erin D Michos,

Targeting Inflammation in Atherosclerosis: RESCUE Trial

Peter Libby,

Targeting Inflammation in Atherosclerosis: CANTOS Trial

Paul M Ridker,

Jean-Claude Tardif,

Articles

Innovations in Ultra-low Contrast PCI

Breda Hennessey

,

Asad Shabbir

,

Alejandro Travieso

,

Nieves Gonzalo

,

Javier Escaned

,

Published:

29 March 2023

Citation:

Interventional Cardiology 2023;18:e09.

DOI:

https://doi.org/10.15420/icr.2022.32
  • Views: Views 45
  • Downloads: Downloads 2
  • Read time: 23 Mins

Sex Differences in Calcified Coronary Lesions

Sean Fitzgerald

,

Maria Rubini Gimenez

,

Abdelhakim Allali

,

Ralph Toelg

,

Dmitriy S. Sulimov

,

Volker Geist

,

Adnan Kastrati

,

Holger Thiele

,

Gert Richardt

,

Mohamed Abdel-Wahab

,

Published:

20 January 2023

Citation:

Interventional Cardiology 2023;18:e02.

DOI:

https://doi.org/10.15420/icr.2022.07
  • Views: Views 275
  • Downloads: Downloads 20
  • Read time: 17 Mins

Lipoprotein(a) and Cardiovascular Disease

Yoshiyasu Minami

,

Daisuke Kinoshita

,

Yusuke Muramatsu

,

Takako Nagata

,

Junya Ako

,

Published:

13 May 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e11.

DOI:

https://doi.org/10.15420/japsc.2021.31
  • Views: Views 1018
  • Downloads: Downloads 56

APSC Consensus Recommendations on Dyslipidaemia

Natalie Koh

,

Brian Ference

,

Stephen J Nicholls

,

Ann Marie Navar

,

Derek P Chew

,

Karam M Kostner

,

Ben He

,

Hung-Fat Tse

,

Jamshed J Dalal

,

Anwar Santoso

,

Junya Ako

,

Hayato Tada

,

Jin Joo Park

,

Mei Lin Ong

,

Eric Lim

,

Tavin Subramaniam

,

Yi-Heng Li

,

Arintaya Phrommintikul

,

SS Iyengar

,

Saumitra Ray

,

Kyung Woo Park

,

Hong Chang Tan

,

Narathip Chunhamaneewat

,

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

Published:

09 December 2021

Citation:

European Cardiology Review 2021;16:e54.

DOI:

https://doi.org/10.15420/ecr.2021.36
  • Views: Views 1431
  • Downloads: Downloads 129
  • Citations: 2